Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017

被引:0
|
作者
Blum, Maxim [1 ]
Geurtsen, Jeroen [2 ]
Herweijer, Eva [1 ]
Sarnecki, Michal [3 ]
Spiessens, Bart [4 ]
Diogo, Gil Reynolds [5 ]
Hermans, Peter [6 ]
Thelwall, Simon [7 ]
Bhattacharya, Alex [7 ]
Verstraeten, Thomas [1 ]
Poolman, Jan [2 ]
Hope, Russell [7 ]
机构
[1] P95 Epidemiol & Pharmacovigilance, Leuven, Belgium
[2] Janssen Vaccines & Prevent BV, Bacterial Vaccines Discovery & Early Dev, Leiden, Netherlands
[3] Janssen Vaccines, Bern, Switzerland
[4] Janssen Pharmaceut, Janssen Res & Dev, Infect Dis & Vaccines, Beerse, Belgium
[5] Janssen Cilag, High Wycombe, England
[6] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, South Africa
[7] UK Hlth Secur Agcy, London, England
关键词
ExPEC; Invasive <italic>E. coli</italic> Disease; IED; Incidence; Sepsis; Bacteraemia; Bloodstream infection; Fatality; Surveillance; Epidemiology; BLOOD-STREAM INFECTIONS; RISK-FACTORS; BACTEREMIA; BURDEN;
D O I
10.1017/S0950268824001584
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Extraintestinal pathogenic Escherichia coli (ExPEC) causes invasive E. coli disease (IED), including bacteraemia and (uro)sepsis, resulting in a high disease burden, especially among older adults. This study describes the epidemiology of IED in England (2013-2017) by combining laboratory surveillance and clinical data. A total of 191 612 IED cases were identified. IED incidence increased annually by 4.4-8.2% across all ages and 2.8-7.6% among adults >= 60 years of age. When laboratory-confirmed urosepsis cases without a positive blood culture were included, IED incidence in 2017 reached 149.4/100 000 person-years among all adults and 368.4/100 000 person-years among adults >= 60 years of age. Laboratory-confirmed IED cases were identified through E. coli-positive blood samples (55.3%), other sterile site samples (26.3%), and urine samples (16.6%), with similar proportions observed among adults >= 60 years of age. IED-associated case fatality rates ranged between 11.8-13.2% among all adults and 13.1-14.7% among adults >= 60 years of age. This study reflects the findings of other published studies and demonstrates IED constitutes a major and growing global health concern disproportionately affecting the older adult population. The high case fatality rates observed despite available antibiotic treatments emphasize the growing urgency for effective intervention strategies. The burden of urosepsis due to E. coli is likely underestimated and requires additional investigation.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United States
    Schmidt, Mark A.
    Blum, Maxim
    Donald, Judy L.
    Meenan, Richard T.
    Carrio, Elvira
    Poolman, Jan
    Neary, Maureen P.
    Verstraeten, Thomas
    Geurtsen, Jeroen
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (03) : 569 - 586
  • [32] Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011-2013
    Zhao, Sheng-Yuan
    Wang, Yan-Chun
    Xiao, Shu-Zhen
    Jiang, Xiao-Fei
    Guo, Xiao-Kui
    Ni, Yu-Xing
    Han, Li-Zhong
    INFECTIOUS DISEASES, 2015, 47 (05) : 310 - 318
  • [33] Neonatal Invasive Haemophilus influenzae Disease in England and Wales: Epidemiology, Clinical Characteristics, and Outcome
    Collins, Sarah
    Litt, David J.
    Flynn, Sally
    Ramsay, Mary E.
    Slack, Mary P. E.
    Ladhani, Shamez N.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (12) : 1786 - 1792
  • [34] Clinical and Molecular Epidemiology of Childhood Invasive Nontypeable Haemophilus influenzae Disease in England and Wales
    Collins, Sarah
    Vickers, Anna
    Ladhani, Shamez N.
    Flynn, Sally
    Platt, Steven
    Ramsay, Mary E.
    Litt, David J.
    Slack, Mary P. E.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (03) : E76 - E84
  • [35] Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013
    von Mollendorf, Claire
    Cohen, Cheryl
    Tempia, Stefano
    Meiring, Susan
    de Gouveia, Linda
    Quan, Vanessa
    Lengana, Sarona
    Karstaedt, Alan
    Dawood, Halima
    Seetharam, Sharona
    Lekalakala, Ruth
    Madhi, Shabir A.
    Klugman, Keith P.
    von Gottberg, Anne
    EMERGING INFECTIOUS DISEASES, 2016, 22 (02) : 261 - 270
  • [36] Incidence of invasive Group B Streptococcus (iGBS) infections and the factors associated with iGBS mortality in adults during 2013-2017: a retrospective study at Thailand's largest national tertiary referral center
    Phoompoung, Pakpoom
    Pirogard, Nantaporn
    Leelaporn, Amornrut
    Angkasekwinai, Nasikarn
    ANNALS OF MEDICINE, 2021, 53 (01) : 715 - 721
  • [37] Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131
    Kallonen, Teemu
    Brodrick, Hayley J.
    Harris, Simon R.
    Corander, Jukka
    Brown, Nicholas M.
    Martin, Veronique
    Peacock, Sharon J.
    Parkhill, Julian
    GENOME RESEARCH, 2017, 27 (08) : 1437 - 1449
  • [38] The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
    Wijayasri, Shinthuja
    Hillier, Kelty
    Lim, Gillian H.
    Harris, Tara M.
    Wilson, Sarah E.
    Deeks, Shelley L.
    PLOS ONE, 2019, 14 (12):
  • [39] Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009-2011
    Verhaegen, J.
    Flamaing, J.
    De Backer, W.
    Delaere, B.
    Van Herck, K.
    Surmont, F.
    Van Laethem, Y.
    Van Damme, P.
    Peetermans, W.
    EUROSURVEILLANCE, 2014, 19 (31): : 14 - 22
  • [40] Preclinical validation of an Escherichia coli O-antigen glycoconjugate for the prevention of serotype O1 invasive disease
    Chorro, Laurent
    Ndreu, Duston
    Patel, Axay
    Kodali, Srinivas
    Li, Zhenghui
    Keeney, David
    Dutta, Kaushik
    Sasmal, Aniruddha
    Illenberger, Arthur
    Torres, C. Lynn
    Pan, Rosalind
    de Monerri, Natalie C. Silmon
    Chu, Ling
    Simon, Raphael
    Anderson, Annaliesa S.
    Donald, Robert G. K.
    MICROBIOLOGY SPECTRUM, 2024, 12 (06):